James P. Waters

James P. Waters

Auto-generated profile, based on publicly available information

James P. Waters

Cooper Medical School of Rowan University, Camden, NJ USA 08103

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Open access
SKSarah Kim
Sarah Kim
AMAnurag Majumdar
Anurag Majumdar
JWJames P. Waters
James P. Waters
GTGena V. Topper
Gena V. Topper
YGYazid Ghanem
Yazid Ghanem
YHYoung Ki Hong
Young Ki Hong
Histotripsy is a novel, non-thermal ultrasound-based technology that utilizes focused acoustic waves to mechanically destroy tumor tissue. This review examines histotripsy's potential to overcome immunoresistance and treat metastatic cancers by inducing potent innate and adaptive anti-tumor immune responses. Tumor destruction releases tumor-specific antigens and damage-associated molecular patterns, facilitating immune activation and transforming the tumor microenvironment from immunologically "cold" to "hot". Preclinical studies show increased CD8+ T cell infiltration, macrophage repolarization towards a pro-inflammatory phenotype, and both local and distant (abscopal) tumor regression. Clinically, patient trials in hepatic tumors report high procedural success and safety, with initial reports of abscopal responses suggesting significant potential systemic benefit. Histotripsy offers potential benefits over radiation therapy, which rarely induces a systemic response, and immune checkpoint inhibitors, which are associated with severe systemic adverse effects. Although further clinical validation is needed, accumulating evidence positions histotripsy as a promising advancement in minimally invasive, immunomodulatory cancer treatment.

16 February 2024 in The American Journal of Surgery
Verified
Journal Article
Closed access
JWJames P. Waters
James P. Waters
YHYoung Ki Hong
Young Ki Hong

22 April 2024 in Clinical Case Reports
Verified
Journal Article
Open access
JWJames P. Waters
James P. Waters
SHSydney Horenstein
Sydney Horenstein
AEAustin Egger
Austin Egger
PJParker Johnsen
Parker Johnsen
TKTae Won Kim
Tae Won Kim
Key Clinical Message: Multidisciplinary team collaboration in the diagnosis of rare tumors such as parosteal lipoma is highly important, especially when suspicious of malignancy. The use of radiological and physical examinations is imperative to monitor recurrence and quality of life.

21 December 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
JWJames P Waters
James P Waters
GTGena V Topper
Gena V Topper
VRVineeth Romiyo
Vineeth Romiyo
IHIan P Hayden
Ian P Hayden
RPRobert A Panico
Robert A Panico
DSDavid D. Shersher
David D. Shersher
Bochdalek hernias arise from a developmental failure of the pleuroperitoneal canal to close, allowing abdominal contents to herniate into the thorax and compress the developing lung parenchyma. In rare cases, Bochdalek hernias may arise in adults and usually present with symptoms related to the hernia. Treatment consists of either open, laparoscopic, or robotic repair to close the defect. We present an unusual case in which an elderly patient presented with a large left-sided Bochdalek hernia containing both an incarcerated stomach and spleen following an uncomplicated robotic left nephrectomy. The hernia was successfully reduced and reconstructed with mesh via open abdominal repair with minimal complications. Repairing these hernias is challenging and, as in this case, required a complex reconstruction of diaphragm with mesh attachment to the ribs. Further reports on acute management of iatrogenic Bochdalek hernias in adults are warranted to better understand long-term post-operative outcomes and optimize management.

22 June 2025 in SurgiColl
Verified
Journal Article
Open access
PDF file
JWJames P. Waters
James P. Waters
PDPuvin Dhurairaj
Puvin Dhurairaj
DPDeep Patel
Deep Patel
DFDavid A. Fuller
David A. Fuller
SKSteven Kozusko
Steven Kozusko
A three-dimensional understanding of fracture morphology improves anatomic reduction and internal fixation, improving care. Here, we describe our protocol for 3-dimensional (3D) printing acute distal radius fracture models for potential use in acute clinical care. We use our institutional 3D editing software (TeraRecon) to edit CT scans to exclusively include the distal radius and its pathology. Then, we use additional 3D editing software in Slicer 3D to convert DICOM files to STL files. Finally, using the Makerbot Replicator Z18 filament printer, we print individual models of distal radius fractures. This protocol will allow for the standardization of methods for 3D printing in acute scenarios, whereas there was no standardized protocol before.

22 June 2024 in Heliyon
Verified
Journal Article
Open access
MMMatthew Christopher Moccia
Matthew Christopher Moccia
JWJames P. Waters
James P. Waters
JDJohn Dibato
John Dibato
YGYazid K. Ghanem
Yazid K. Ghanem
HJHansa Joshi
Hansa Joshi
SMSteven J. McClane
Steven J. McClane
There is a paucity of recent literature investigating the sole effect of income level on the treatment and survival of patients with rectal cancer. We analyzed all cases of rectal cancer in the Rectal Cancer PUF of the NCDB from 2010 to 2020. We utilized the Median Income Quartiles 2016–2020 to define our income levels. The two lower quartiles were combined to create a lower income group, with the upper two quartiles creating the higher income group. The total cohort included 201,329 patients, with 116,843 and 84,486 in the higher and lower income groups, respectively. Lower income patients were more often black (17 % vs 6 %), lived farther from the nearest hospital (33.5 miles vs 25.7 miles) despite being more likely to live in urban areas (25 % vs 7 %), and had lower levels of private insurance (36 % vs 49 %). They underwent more APRs (17 % vs 14 %) and had a 13 % higher chance of undergoing an open operation (OR 1.13, CI 1.09–1.17). Higher income patients had a 12 % reduction in 90-day (OR 0.88, 95 % CI 0.82–0.96) and overall mortality (OR 0.88, 95 % CI 0.86–0.89). Clinicians should be aware that lower income patients are often faced with unique challenges that may impact care delivery.